161 Longitudinal tau PET and cognition 27. Visser D, Wolters EE, Verfaillie SC, Coomans EM, Timmers T, Tuncel H, et al. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging. 2020;47:3165-75. 28. Tijms BM, Willemse EA, Zwan MD, Mulder SD, Visser PJ, van Berckel BN, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-β 1–42 analysis results. Clinical Chemistry. 2018;64:576-85. 29. Tuncel H, Visser D, Yaqub M, Timmers T, Wolters EE, Ossenkoppele R, et al. Effect of Shortening the Scan Duration on Quantitative Accuracy of [18 F] Flortaucipir Studies. Molecular Imaging and Biology. 2021;23:604-13. 30. Visser D, Tuncel H, Ossenkoppele R, Yaqub MM, Wolters EE, Timmers T, et al. Longitudinal tau PET using 18F-flortaucipir: the Effect of relative Cerebral Blood Flow on (semi) quantitative parameters. Journal of Nuclear Medicine. 2022. 31. Golla SS, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, et al. Quantification of tau load using [18F] AV1451 PET. Molecular imaging and biology. 2017;19:963-71. 32. Tuncel H, Visser D, Yaqub M, Timmers T, Wolters EE, Ossenkoppele R, et al. Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F] Flortaucipir Studies. Molecular imaging and biology. 2021;23:604-13. 33. Visser D, Wolters EE, Verfaillie SC, Coomans EM, Timmers T, Tuncel H, et al. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease. European journal of nuclear medicine and molecular imaging. 2020;47:3165-75. 34. Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human brain mapping. 2003;19:224-47. 35. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbøl S, Frøkjær VG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24:969-79. 36. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-87. 37. Timmers T, Ossenkoppele R, Wolters EE, Verfaillie SC, Visser D, Golla SS, et al. Associations between quantitative [18 F] flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum. Alzheimer’s research & therapy. 2019;11:1-12. 38. Jutten RJ, Sikkes SA, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, et al. Identifying sensitive measures of cognitive decline at different clinical stages of Alzheimer’s disease. Journal of the International Neuropsychological Society. 2021;27:426-38. 39. Brown D, Hunter R, Wyper D, Patterson J, Kelly R, Montaldi D, et al. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer’s disease: a SPECT blood flow study. Journal of psychiatric research. 1996;30:109-26. 40. Duan W, Zhou GD, Balachandrasekaran A, Bhumkar AB, Boraste PB, Becker JT, et al. Cerebral blood flow predicts conversion of mild cognitive impairment into Alzheimer’s disease and cognitive decline: An arterial spin labeling follow-up study. Journal of Alzheimer’s Disease. 2021;82:293-305. 6
RkJQdWJsaXNoZXIy MjY0ODMw